This academic article, “Nutritional priorities to support GLP‐1 therapy for obesity,” is a joint advisory from several prominent American health organizations. It examines the use of GLP-1 receptor agonists (GLP-1s) for obesity treatment, highlighting their efficacy in weight reduction and other clinical benefits while also addressing significant challenges like gastrointestinal side effects, potential nutrient deficiencies, and loss of muscle and bone mass. The authors emphasize the crucial role of comprehensive nutritional and lifestyle counseling before, during, and after GLP-1 therapy to maximize benefits, mitigate adverse effects, and promote long-term weight management and overall health, especially given the high costs and discontinuation rates associated with these medications. The advisory also touches on health equity concerns related to GLP-1 access and the impact of food and nutrition insecurity.
Read more: Nourishing GLP-1 Therapy for Obesity
Audio Overview (Google NotebookLM)
(53 minutes 30 seconds)
